{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:11:43Z","timestamp":1794867103413,"version":"4.9.1"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cca.2026.121073","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:26:02Z","timestamp":1778567162000},"page":"121073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Biochemical diagnosis of pheochromocytoma and paraganglioma: analytical challenges and perspectives for optimization"],"prefix":"10.1016","volume":"590","author":[{"given":"Fran\u00e7ois","family":"Fraissinet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9ophile","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Girot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ry","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00e9tan","family":"Pr\u00e9vost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine-Guy","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121073_bb0005","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Endocrine Society, pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jc.2002-021913","article-title":"Editorial: biochemical diagnosis of pheochromocytoma--is it time to switch to plasma-free metanephrines?","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0015","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1373\/clinchem.2018.290791","article-title":"Biochemical diagnosis of pheochromocytoma, a rediscovered catecholamine-metabolizing tumor","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0020","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the working group on endocrine hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2026.121073_bb0025","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/clinchem\/hvab060","article-title":"Harmonization of LC-MS\/MS measurements of plasma free normetanephrine, metanephrine, and 3-methoxytyramine","volume":"67","author":"Peitzsch","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ando.2010.04.004","article-title":"Baudin, groupe des tumeurs endocrines (GTE France), chromogranin a assay in clinical practice","volume":"71","author":"d'Herbomez","year":"2010","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.cca.2026.121073_bb0035","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/ERC-17-0269","article-title":"Chromogranin a as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame","volume":"25","author":"Marotta","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cca.2026.121073_bb0040","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.7150\/thno.35458","article-title":"Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p\/TSC2\/mTOR axis in metastatic pheochromocytoma\/paraganglioma","volume":"9","author":"Calsina","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.cca.2026.121073_bb0045","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1210\/clinem\/dgae797","article-title":"COMETE-TACTIC study group, on behalf of the, biomarkers improving genetic and metastatic disease prediction in paraganglioma: insights from a prospective study","volume":"110","author":"Drossart","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.2002-021251","article-title":"A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines","volume":"88","author":"Sawka","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1507\/endocrj.EJ14-0384","article-title":"Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma","volume":"62","author":"Kim","year":"2015","journal-title":"Endocr. J."},{"key":"10.1016\/j.cca.2026.121073_bb0060","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell Tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0065","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","author":"Eisenhofer","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-017-1300-y","article-title":"Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review","volume":"56","author":"D\u00e4rr","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2026.121073_bb0075","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors","volume":"94","author":"de Jong","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0080","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/clinchem\/hvac025","article-title":"Diet is a small contributor to interindividual variation of urinary free catecholamines and related metabolites determined by LC-MS\/MS for the screening of catecholamine-secreting Tumors","volume":"68","author":"Violin","year":"2022","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1373\/clinchem.2006.075218","article-title":"Stability of urinary fractionated metanephrines and catecholamines during collection, shipment, and storage of samples","volume":"53","author":"Willemsen","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0090","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0731-7085(99)00308-8","article-title":"Evaluation of degradation of urinary catecholamines and metanephrines and deconjugation of their sulfoconjugates using stability-indicating reversed-phase ion-pair HPLC with electrochemical detection","volume":"22","author":"Chan","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2026.121073_bb0095","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1530\/EC-17-0071","article-title":"Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations","volume":"6","author":"Corcuff","year":"2017","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.cca.2026.121073_bb0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12020-020-02267-8","article-title":"Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma","volume":"69","author":"Wang","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2026.121073_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1515\/cclm-2015-0044","article-title":"Preservation of urine free catecholamines and their free O-methylated metabolites with citric acid as an alternative to hydrochloric acid for LC-MS\/MS-based analyses","volume":"54","author":"Peitzsch","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2020.12.009","article-title":"Stabilization of urinary biogenic amines measured in clinical chemistry laboratories","volume":"514","author":"Eugster","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-19-1016","article-title":"Overnight\/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?","volume":"182","author":"Peitzsch","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2026.121073_bb0120","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cca.2012.02.023","article-title":"Synthetic calibrators for the analysis of total metanephrines in urine: revisiting the conditions of hydrolysis","volume":"413","author":"Simonin","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0125","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2012.12.031","article-title":"Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites","volume":"418","author":"Peitzsch","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0004563214546560","article-title":"A novel method for the measurement of plasma metanephrines using online solid phase extraction-liquid chromatography tandem mass spectrometry","volume":"52","author":"Adaway","year":"2015","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0140","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4158\/EP10205.RA","article-title":"Endocrine hypertension: then and now","volume":"16","author":"Young","year":"2010","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cca.2026.121073_bb0145","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","author":"Eisenhofer","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cca.2026.121073_bb0150","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.clinbiochem.2016.05.008","article-title":"Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas","volume":"49","author":"Patin","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.CIR.90.1.248","article-title":"Mechanisms responsible for sympathetic activation by cigarette smoking in humans","volume":"90","author":"Grassi","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121073_bb0160","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0895-7061(98)00022-3","article-title":"Acute effects of cigarette smoking on platelet function and plasma catecholamines in hypertensive and normotensive men","volume":"11","author":"Mundal","year":"1998","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2026.121073_bb0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2265.2009.03761.x","article-title":"Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasma","volume":"73","author":"Deutschbein","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2026.121073_bb0170","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.cca.2012.06.009","article-title":"Plasma normetanephrine concentrations are affected by dietary sodium intake","volume":"413","author":"Kerstens","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0175","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0026-0495(80)90078-5","article-title":"Enhanced plasma norepinephrine response to upright posture and oral glucose administration in elderly human subjects","volume":"29","author":"Young","year":"1980","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2026.121073_bb0180","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1373\/clinchem.2006.076489","article-title":"Is supine rest necessary before blood sampling for plasma metanephrines?","volume":"53","author":"Lenders","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0004563216646395","article-title":"Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted\/seated patients","volume":"54","author":"Casey","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0190","doi-asserted-by":"crossref","first-page":"e3689","DOI":"10.1210\/clinem\/dgac390","article-title":"Preanalytical considerations and outpatient versus inpatient tests of plasma Metanephrines to diagnose pheochromocytoma","volume":"107","author":"Pommer","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/EJE-13-0673","article-title":"Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma","volume":"170","author":"Pamporaki","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2026.121073_bb0200","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1515\/cclm-2020-0022","article-title":"Blood sampling for metanephrines comparing venipuncture vs. indwelling intravenous cannula in healthy subjects","volume":"58","author":"Eijkelenkamp","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0205","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/00365513.2021.1904280","article-title":"Plasma or serum, which is the better choice for the measurement of metanephrines?","volume":"81","author":"Yu","year":"2021","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2026.121073_bb0210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/00365513.2021.1980901","article-title":"Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma","volume":"81","author":"Wang","year":"2021","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2026.121073_bb0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.0300-0664.2001.01446.x","article-title":"Study of diurnal fluctuations of plasma methoxyamines in healthy volunteers","volume":"56","author":"Hoizey","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2026.121073_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.25107","article-title":"Effects of blood collection tubes on the quantification of catecholamines and their O-methylated metabolites by liquid chromatography coupled with tandem mass spectrometry","volume":"38","author":"Su","year":"2024","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.cca.2026.121073_bb0225","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1515\/cclm-2019-0020","article-title":"Short-term stability of free metanephrines in plasma and whole blood","volume":"58","author":"Danese","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0230","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1373\/clinchem.2003.023135","article-title":"Stability of plasma free metanephrines during collection and storage as assessed by an optimized HPLC method with electrochemical detection","volume":"49","author":"Willemsen","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0235","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1258\/acb.2011.010275","article-title":"A study of longer-time stability of plasma free metanephrines","volume":"48","author":"Ross","year":"2011","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0240","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2265.2012.04340.x","article-title":"Rapid circulatory clearances and half-lives of plasma free metanephrines","volume":"77","author":"Eisenhofer","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2026.121073_bb0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/cs0880533","article-title":"Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism?","volume":"88","author":"Eisenhofer","year":"1995","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.cca.2026.121073_bb0250","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-14-0730","article-title":"Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma","volume":"172","author":"Weismann","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2026.121073_bb0255","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1515\/cclm-2013-0406","article-title":"Radioimmunoassay of free plasma metanephrines for the diagnosis of catecholamine-producing tumors","volume":"52","author":"Pussard","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cca.2013.12.044","article-title":"Enzyme and acid deconjugation of plasma sulfated metanephrines","volume":"430","author":"Glauser","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0265","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1373\/clinchem.2008.104083","article-title":"Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography-tandem mass spectrometry","volume":"54","author":"Marney","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0270","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cca.2019.05.024","article-title":"Liquid chromatography tandem mass spectrometry for plasma metadrenalines","volume":"495","author":"Davies","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1373\/clinchem.2003.024703","article-title":"Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma","volume":"50","author":"Lagerstedt","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0280","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3343\/alm.2015.35.5.519","article-title":"Development and validation of liquid chromatography-tandem mass spectrometry method for quantification of plasma metanephrines for differential diagnosis of adrenal incidentaloma","volume":"35","author":"Lee","year":"2015","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0285","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cca.2012.06.006","article-title":"Performance characteristics of an LC-MS\/MS method for the determination of plasma metanephrines","volume":"413","author":"Petteys","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0290","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1373\/clinchem.2014.233551","article-title":"Multiple reaction monitoring with multistage fragmentation (MRM3) detection enhances selectivity for LC-MS\/MS analysis of plasma free metanephrines","volume":"61","author":"Wright","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1258\/acb.2012.012112","article-title":"Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma","volume":"50","author":"Peitzsch","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0300","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1258\/acb.2011.010235","article-title":"Improved plasma free metadrenaline analysis requires mixed mode cation exchange solid-phase extraction prior to liquid chromatography tandem mass spectrometry detection","volume":"48","author":"Clarke","year":"2011","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0305","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1007\/s00216-022-03984-x","article-title":"An automated magnetic bead extraction method for measuring plasma metanephrines and 3-methoxytyramine using liquid chromatography tandem mass spectrometry","volume":"414","author":"Yu","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0310","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1021\/acs.analchem.0c01263","article-title":"In matrix derivatization combined with LC-MS\/MS results in ultrasensitive quantification of plasma free Metanephrines and catecholamines","volume":"92","author":"van Faassen","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0315","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1373\/clinchem.2007.087114","article-title":"Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry","volume":"53","author":"de Jong","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0320","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jmsacl.2021.08.001","article-title":"A high sensitivity LC-MS\/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine","volume":"21","author":"Smy","year":"2021","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.cca.2026.121073_bb0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.trac.2016.01.027","article-title":"Impact of LC-MS\/MS on the laboratory diagnosis of catecholamine-producing tumors","volume":"84","author":"Eisenhofer","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0330","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jchromb.2011.06.013","article-title":"Quantitative measurement of plasma free metanephrines by ion-pairing solid phase extraction and liquid chromatography-tandem mass spectrometry with porous graphitic carbon column","volume":"879","author":"He","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2026.121073_bb0335","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/clinchem\/39.1.97","article-title":"Determination of metanephrines in plasma by liquid chromatography with electrochemical detection","volume":"39","author":"Lenders","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0340","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jchromb.2015.07.004","article-title":"Validation of an assay for quantification of free normetanephrine, metanephrine and methoxytyramine in plasma by high performance liquid chromatography with coulometric detection: comparison of peak-area vs. peak-height measurements","volume":"1002","author":"Nie\u0107","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2026.121073_bb0345","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/clinchem\/47.6.1061","article-title":"Quantification of unconjugated metanephrines in human plasma without interference by acetaminophen","volume":"47","author":"Roden","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0350","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1258\/acb.2009.009153","article-title":"Pilot quality assurance programme for plasma metanephrines","volume":"47","author":"Pillai","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0355","article-title":"An isotope dilution-liquid chromatography-tandem mass spectrometry based candidate reference measurement procedure for the simultaneous quantification of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum and plasma","author":"Kandler","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0360","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1373\/clinchem.2012.190934","article-title":"Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum","volume":"59","author":"Botelho","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0365","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-253597","article-title":"Sulfasalazine as a cause of false-positive elevation of urinary normetanephrine in patients with adrenal mass and suspected phaeochromocytoma: a diagnostic challenge","volume":"16","author":"Zuling","year":"2023","journal-title":"BMJ Case Rep."},{"issue":"Pt 5","key":"10.1016\/j.cca.2026.121073_bb0370","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/000456328802500517","article-title":"Urinary catecholamine assay by HPLC: in vitro interference by some drugs","volume":"25","author":"Davidson","year":"1988","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0375","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1258\/0004563041201626","article-title":"Paracetamol-associated interference in an HPLC-ECD assay for urinary free metadrenalines and catecholamines","volume":"41","author":"Davidson","year":"2004","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0380","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJM199502093320617","article-title":"Effect of buspirone on urinary catecholamine assays","volume":"332","author":"Cook","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0385","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/clinchem\/hvac060","article-title":"A negative internal standard in urinary Metanephrines quantification","volume":"68","author":"Alarcan","year":"2022","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0390","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0004563213494079","article-title":"Interference from Indian diet on the internal standard in a commercial method for the measurement of urinary metanephrines by high-performance liquid chromatography with electrochemical detection","volume":"51","author":"Madhavaram","year":"2014","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0395","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1373\/clinchem.2012.186601","article-title":"Ionic cross talk can lead to overestimation of 3-methoxytyramine during quantification of metanephrines by mass spectrometry","volume":"58","author":"Twentyman","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0400","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1373\/clinchem.2015.239962","article-title":"Interference from 3-O-methyldopa with ultra-high performance LC-MS\/MS measurements of plasma metanephrines: chromatographic separation remains important","volume":"61","author":"Peitzsch","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0405","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1469066719862423","article-title":"Matrix interference in LC-ESI-MS\/MS analysis of metanephrines in protein precipitated plasma samples","volume":"26","author":"Rebane","year":"2020","journal-title":"Eur. J. Mass Spectrom. (Chichester)"},{"key":"10.1016\/j.cca.2026.121073_bb0410","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.clinbiochem.2014.04.003","article-title":"Analytical interference of 4-hydroxy-3-methoxymethamphetamine with the measurement of plasma free normetanephrine by ultra-high pressure liquid chromatography-tandem mass spectrometry","volume":"47","author":"Dunand","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0415","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0004563218755817","article-title":"Falsely elevated plasma metanephrine in patients taking midodrine","volume":"55","author":"Emms","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0420","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/0004563218818199","article-title":"Falsely elevated plasma 3-methoxytyramine in a patient receiving midodrine therapy","volume":"56","author":"Treasure","year":"2019","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122391","article-title":"Quantitation using HRMS: a new tool for rapid, specific and sensitive determination of catecholamines and deconjugated methanephrines metanephrines in urine","volume":"1166","author":"Lefeuvre","year":"2021","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2026.121073_bb0430","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0029-1237699","article-title":"False positive test results for pheochromocytoma from 2000 to 2008","volume":"118","author":"Yu","year":"2010","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.cca.2026.121073_bb0435","article-title":"False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade","volume":"31","author":"Sch\u00fcrfeld","year":"2024","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cca.2026.121073_bb0440","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2026.121073_bb0445","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.clinbiochem.2016.06.004","article-title":"No influence of antihypertensive agents on plasma free metanephrines","volume":"49","author":"Osinga","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0450","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0004563213487894","article-title":"Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine","volume":"51","author":"Eisenhofer","year":"2014","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0455","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0031-1299759","article-title":"Pheochromocytoma and paraganglioma: recent progress and new vistas for improved patient care","volume":"44","author":"Eisenhofer","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cca.2026.121073_bb0460","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121073_bb0465","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10571-010-9595-8","article-title":"Chromogranin a as a crucial factor in the sorting of peptide hormones to secretory granules","volume":"30","author":"Elias","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.cca.2026.121073_bb0470","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EC-14-0027","article-title":"Biological function and clinical relevance of chromogranin a and derived peptides","volume":"3","author":"D\u2019amico","year":"2014","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.cca.2026.121073_bb0475","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00424-017-2030-y","article-title":"Circulating chromogranin a and its fragments as diagnostic and prognostic disease markers","volume":"470","author":"Corti","year":"2018","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.cca.2026.121073_bb0480","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2362.1998.00305.x","article-title":"Chromogranin a: its clinical value as marker of neuroendocrine tumours","volume":"28","author":"Nobels","year":"1998","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.cca.2026.121073_bb0485","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ecl.2010.12.001","article-title":"The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.cca.2026.121073_bb0490","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1373\/clinchem.2011.176099","article-title":"Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin a, chromogranin B, and cocaine- and amphetamine-regulated transcript","volume":"58","author":"Bech","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0495","first-page":"384","article-title":"Chromogranin A (CgA)--the influence of various factors in vivo and in vitro, and existing disorders on it's concentration in blood","volume":"61","author":"Glinicki","year":"2010","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.cca.2026.121073_bb0500","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1530\/eje.0.1500299","article-title":"Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin a levels in man","volume":"150","author":"Giusti","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2026.121073_bb0505","doi-asserted-by":"crossref","first-page":"E1731","DOI":"10.1210\/jc.2012-1548","article-title":"Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin a in healthy subjects","volume":"97","author":"Mosli","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0510","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2014.04.026","article-title":"Preanalytical factors of importance for measurement of chromogranin A","volume":"436","author":"Pedersen","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2026.121073_bb0515","first-page":"25","article-title":"Chromogranin a (CgA) - the influence of various factors in vivo and in vitro, and existing disorders on it\u2019s concentration in blood","volume":"62","author":"Glinicki","year":"2011","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.cca.2026.121073_bb0520","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000369818","article-title":"Chromogranin a in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution","volume":"100","author":"Massironi","year":"2014","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.cca.2026.121073_bb0525","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MED.0000000000000215","article-title":"Chromogranin a: any relevance in neuroendocrine tumors?","volume":"23","author":"Kidd","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.cca.2026.121073_bb0530","first-page":"415","article-title":"Chromogranin a (CgA) - characteristic of the currently available laboratory methods and conditions which can influence the results","volume":"60","author":"Glinicki","year":"2009","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.cca.2026.121073_bb0535","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/00045632231160371","article-title":"Stability assessment of serum tumour markers: calcitonin, chromogranin a, thyroglobulin and anti-thyroglobulin antibodies","volume":"60","author":"Thirkettle","year":"2023","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121073_bb0540","article-title":"Comparison of two chromogranin a assays and investigation of nonlinear specimens","volume":"32","author":"Erickson","year":"2022","journal-title":"Pract. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0545","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3390\/diagnostics11122400","article-title":"Performance evaluation of the KRYPTOR compact PLUS Analyzer-based B.R.A.H.M.S. CgA II KRYPTOR assay for chromogranin a measurement","volume":"11","author":"Choi","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cca.2026.121073_bb0550","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/clinchem\/hvab191","article-title":"Antibody-free quantification of serum chromogranin a by targeted mass spectrometry","volume":"67","author":"Weber","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0555","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/clinchem\/45.4.549","article-title":"Library of sequence-specific radioimmunoassays for human chromogranin a","volume":"45","author":"Jensen","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0560","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.bjc.6690013","article-title":"A new human chromogranin a (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)","volume":"79","author":"Degorce","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cca.2026.121073_bb0565","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3892\/etm.2015.2634","article-title":"Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms","volume":"10","author":"Wang","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0570","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/MPA.0000000000001184","article-title":"Chromogranin a in the follow-up of gastroenteropancreatic neuroendocrine neoplasms: is it really game over? A systematic review and meta-analysis","volume":"47","author":"Rossi","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.cca.2026.121073_bb0575","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/diagnostics10110881","article-title":"Limited diagnostic utility of chromogranin a measurements in workup of neuroendocrine Tumors","volume":"10","author":"Baekdal","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cca.2026.121073_bb0580","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5001\/omj.2017.71","article-title":"Chromogranin a as a biochemical marker for neuroendocrine tumors: a single center experience at Royal Hospital, Oman","volume":"32","author":"Al-Risi","year":"2017","journal-title":"Oman Med. J."},{"key":"10.1016\/j.cca.2026.121073_bb0585","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cca.2013.08.021","article-title":"Harmonization of laboratory testing - current achievements and future strategies","volume":"432","author":"Tate","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0590","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1515\/cclm-2013-0075","article-title":"Harmonization in laboratory medicine: the complete picture","volume":"51","author":"Plebani","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0595","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3343\/alm.2014.34.3.187","article-title":"Harmonization: the sample, the measurement, and the report","volume":"34","author":"Miller","year":"2014","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0600","first-page":"121","article-title":"Harmonisation of laboratory testing","volume":"33","author":"Tate","year":"2012","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.cca.2026.121073_bb0605","first-page":"95","article-title":"Harmonisation of measurement procedures: how do we get it done?","volume":"33","author":"Gantzer","year":"2012","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.cca.2026.121073_bb0610","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1373\/clinchem.2011.166041","article-title":"Patient safety and clinical effectiveness as imperatives for achieving harmonization inside and outside the clinical laboratory","volume":"57","author":"McLawhon","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0615","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1515\/cclm-2018-0594","article-title":"Harmonization in laboratory medicine: Blowin\u2019 in the wind","volume":"56","author":"Plebani","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2023.100126","article-title":"Harnessing liquid biopsies: exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine","volume":"2","author":"Bamodu","year":"2023","journal-title":"J. Liq. Biopsy."},{"key":"10.1016\/j.cca.2026.121073_bb0625","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","article-title":"Current and future perspectives of liquid biopsies in genomics-driven oncology","volume":"20","author":"Heitzer","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cca.2026.121073_bb0630","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/10408363.2018.1425976","article-title":"Advances in liquid biopsy on-chip for cancer management: technologies, biomarkers, and clinical analysis","volume":"55","author":"Tadimety","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.cca.2026.121073_bb0635","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231192401","article-title":"Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA","volume":"15","author":"Yaghoubi Naei","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.cca.2026.121073_bb0640","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1039\/C9TB01490J","article-title":"Advanced liquid biopsy technologies for circulating biomarker detection","volume":"7","author":"Soda","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.cca.2026.121073_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2019.115803","article-title":"Recent advances in potentiometric biosensors","volume":"124","author":"Ding","year":"2020","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0650","article-title":"The liquid biopsy consortium: challenges and opportunities for early cancer detection and monitoring","volume":"4","author":"Batool","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0655","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02648725.2022.2108994","article-title":"Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications","volume":"38","author":"Shah","year":"2022","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.cca.2026.121073_bb0660","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1530\/ERC-21-0216","article-title":"A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy","volume":"28","author":"Pacak","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cca.2026.121073_bb0665","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/ERC-10-0211","article-title":"Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma","volume":"18","author":"Eisenhofer","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cca.2026.121073_bb0670","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/1078-0432.CCR-15-1576","article-title":"In vivo detection of succinate by magnetic resonance spectroscopy as a Hallmark of SDHx mutations in paraganglioma","volume":"22","author":"Lussey-Lepoutre","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121073_bb0675","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1210\/clinem\/dgac474","article-title":"Succinate: a serum biomarker of SDHB-mutated paragangliomas and pheochromocytomas","volume":"107","author":"Lamy","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0680","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gim.2021.08.004","article-title":"Cancer variant interpretation group UK (CanVIG-UK), quantifying evidence toward pathogenicity for rare phenotypes: the case of succinate dehydrogenase genes, SDHB and SDHD","volume":"24","author":"Garrett","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0685","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/cancers13071522","article-title":"MicroRNAs, long non-coding RNAs, and circular RNAs: potential biomarkers and therapeutic targets in pheochromocytoma\/paraganglioma","volume":"13","author":"Turai","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121073_bb0690","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/metabo12020131","article-title":"The role of the metabolome and non-coding RNA on pheochromocytomas and paragangliomas: an Update","volume":"12","author":"Bou\u00e7a","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2026.121073_bb0695","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cca.2022.07.018","article-title":"Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma","volume":"534","author":"Eugster","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0700","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ando.2019.04.003","article-title":"Emerging molecular markers of metastatic pheochromocytomas and paragangliomas","volume":"80","author":"Goncalves","year":"2019","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.cca.2026.121073_bb0705","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/biology10070580","article-title":"A critical appraisal of contemporary and novel biomarkers in pheochromocytomas and adrenocortical Tumors","volume":"10","author":"Tsoli","year":"2021","journal-title":"Biol.-Basel"},{"key":"10.1016\/j.cca.2026.121073_bb0710","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","article-title":"Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography","volume":"104","author":"Timmers","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cca.2026.121073_bb0715","doi-asserted-by":"crossref","first-page":"R627","DOI":"10.1530\/ERC-19-0165","article-title":"Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups","volume":"26","author":"Ta\u00efeb","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cca.2026.121073_bb0720","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.3390\/cancers15184666","article-title":"Image-guided precision medicine in the diagnosis and treatment of pheochromocytomas and paragangliomas","volume":"15","author":"Gabiache","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121073_bb0725","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121073_bb0730","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4158\/EP-2017-0057","article-title":"Pheochromocytoma: a genetic and diagnostic update","volume":"24","author":"Mercado-Asis","year":"2018","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cca.2026.121073_bb0735","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.semnuclmed.2013.06.005","article-title":"Current and future trends in the anatomical and functional imaging of head and neck paragangliomas","volume":"43","author":"Ta\u00efeb","year":"2013","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0740","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/joim.12507","article-title":"Precision medicine in pheochromocytoma and paraganglioma: current and future concepts","volume":"280","author":"Bj\u00f6rklund","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0745","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/CCO.0000000000000249","article-title":"Pheochromocytoma and paraganglioma: molecular testing and personalized medicine","volume":"28","author":"Burnichon","year":"2016","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.cca.2026.121073_bb0750","doi-asserted-by":"crossref","DOI":"10.1530\/JME-22-0167","article-title":"Genetic bases of pheochromocytoma and paraganglioma","volume":"70","author":"Casc\u00f3n","year":"2023","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.cca.2026.121073_bb0755","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1093\/hmg\/ddaa201","article-title":"Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine","volume":"29","author":"Casey","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cca.2026.121073_bb0760","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/jpm11111239","article-title":"Precision medicine in phaeochromocytoma and paraganglioma","volume":"11","author":"Winzeler","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0765","doi-asserted-by":"crossref","DOI":"10.3390\/ph17030354","article-title":"The management of phaeochromocytomas and paragangliomas in the era of precision medicine: where are we now? Evidence-Based systemic treatment options and future cluster oriented perspectives","volume":"17","author":"Bracigliano","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.cca.2026.121073_bb0770","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0009-8981(85)90261-X","article-title":"Interference of labetalol metabolites in the determination of plasma catecholamines by HPLC with electrochemical detection","volume":"150","author":"Bouloux","year":"1985","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121073_bb0775","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jalm\/jfaf023","article-title":"Rifampicin interference in urinary normetanephrine","volume":"10","author":"Gillardin","year":"2025","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.cca.2026.121073_bb0780","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1373\/clinchem.2004.032912","article-title":"Pitfall in HPLC assay for urinary metanephrines: an unusual type of interference caused by methenamine intake","volume":"50","author":"van Laarhoven","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121073_bb0785","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1210\/jc.2014-2151","article-title":"Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas\/paragangliomas due to succinate dehydrogenase deficiency","volume":"99","author":"Richter","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121073_bb0790","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0376","article-title":"Metabolomics in paraganglioma: applications and perspectives from genetics to therapy","volume":"30","author":"Richter","year":"2023","journal-title":"Endocr. Relat. Cancer"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812600255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812600255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:27:59Z","timestamp":1783643279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989812600255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":158,"alternative-id":["S000989812600255X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121073","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical diagnosis of pheochromocytoma and paraganglioma: analytical challenges and perspectives for optimization","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121073"}}